Introduction
Classical pituitary apoplexy is a medical emergency and rapid replacement with hydrocortisone may be lifesaving. It is caused by haemorrhage and/or infarction of a tumour within the pituitary gland. A high index of clinical suspicion is essential to diagnose this condition as prompt management may be life and vision saving. This guideline aims to take the non-specialist through the initial phase of assessment and management.
Clinical presentation
The diagnosis of pituitary apoplexy is often delayed as ~80% of these patients will have no previous history of a pituitary problem and the clinical features mimic other more common neurological conditions.
• A diagnosis of pituitary apoplexy should be considered in all patients who have acute severe headache and any of the following:
-patients in whom subarachnoid haemorrhage (SAH) and meningitis have been excluded -patients with neuro-ophthalmic signs -patients with pre-existing pituitary tumours
• Acute severe headache is the most common and earliest manifestation. After emergency care: where should patients with pituitary apoplexy be managed?
Once the diagnosis has been confirmed, it is recommended that all patients be transferred once medically stabilised, following liaison and advice from the specialist neurosurgical/endocrine team, to the local neurosurgical/ endocrine team as soon as possible. Neurosurgical high dependency unit (HDU) facilities must be available. This team must have access to specialist endocrine and ophthalmological expertise. These patients should then be managed according the Society for Endocrinology UK guidelines for the management of pituitary apoplexy (1).
Indications for surgery
Patients should first be stabilised medically with steroid replacement, if needed, before surgical intervention. Studies have shown significantly greater improvement in visual acuity and visual field defects in patients who had early surgery (within 8 days). Surgical intervention should be considered in patients with:
• Severely reduced visual acuity • Severe and persistent visual field defects • Deteriorating level of consciousness
Long-term follow-up
All patients with pituitary apoplexy need follow-up by endocrine and neurosurgical teams. They require repeat assessment of pituitary and visual function, at 4-6 weeks. Thereafter, 6-12 monthly follow-up to optimise hormonal replacement and to monitor tumour progression/recurrence.
Summary
See Fig. 1 for an emergency management summary.
Pituitary apoplexy is a rare and potentially lethal endocrine emergency, characterised by acute severe headache, visual defects, and/or reduced consciousness.
The clinical presentation often mimics other more common neurological emergencies.
Prompt resuscitation and corticosteroid replacement may be lifesaving.
MRI scan is the investigation of choice. Urgent discussion with the regional neurosurgical/ endocrine team is essential.
Surgical intervention should be considered in patients with severe and persisting visual defects or in those with deteriorating level of consciousness after medical stabilisation and steroid replacement.
